gi

Gilead Sciences

GILD
NASDAQ
$139.71

Does Gilead Sciences have pricing power in its industry?

Gilead Sciences shows weak pricing power. Margins are below industry norms and may be declining. The business appears to compete primarily on price, leaving it vulnerable to cost increases and competitive pressure on profitability.